drugset / Trial / NCT00155883
Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective is to determine the tumor response rate of bi-weekly docetaxel plus 24-hour infusion of high-dose 5-FU/leucovorin chemotherapy for patients with inoperable advanced gastric cancer.
Timeline
- Start
- 2004-06
- Primary completion
- —
- Completion
- 2005-07
Outcome
Outcome not reported
Stopped (Enrollment): “slow a accrul due to many competitive trials.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leucovorin | Small molecule | — | — |
| Subject | Taxteral | Unknown | — | — |
| Subject | fluorouracil | Small molecule | — | — |